BR55 in Prostate Cancer: an Exploratory Clinical Trial

Summary

The purpose of this study is to determine whether BR55 is able to identify areas of VEGFR2 expression in human prostate by ultrasound molecular imaging. This will be compared with histopathology analysis (location based on expression of VEGFR2 in tissue specimens determined by immuno-histochemistry, IHC).

Timeline

Start

2010-07

Primary completion

2012-12

Completion

2012-12

Drugs

Indications